Tai-chi / Qi-gong in Patients With Patients With Gynecological Malignancies

Sponsor
Sheba Medical Center (Other)
Overall Status
Withdrawn
CT.gov ID
NCT01880996
Collaborator
Tel Aviv University (Other)
0
1
2
12
0

Study Details

Study Description

Brief Summary

Oncologic patients often report increased fatigue during and after chemotherapy. Evidence suggests Tai-chi/Qi-gong may improve quality of life (QOL) in oncologic patients treated with chemotherapy. Previous studies, mostly performed in a population of breast cancer patients, have demonstrated the benefits of Tai-chi/Qi-gong practice in improving quality of life (1), reducing bone resorption (2), preventing the decrease of blood counts (WBC and Hb) (3), and reducing inflammation (4).

The aim of this pilot study is to evaluate the effect of Tai-chi/Qi-gong on QOL, sleep, and fatigue in patients with gynecological malignancies, particularly in patients with ovarian cancer.

Condition or Disease Intervention/Treatment Phase
  • Other: Tai-chi/Qi-gong
Phase 1/Phase 2

Detailed Description

Tai-chi/Qi-gong is a complementary medicine technique that synergizes the mind-body connection. The technique employs a series of positions and movements that are performed in a slow, flowing manner to help a person concentrate on breathing and motion.

The effect of Tai-chi/Qi-gong on fatigue, quality of life, and quality of sleep will be assessed in gynecological cancer patients. This trial will recruit 60 patients with gynecological malignancies, who receive first or second line chemotherapy. The patients will be allocated according to their preference to either the study or the control group. The Tai-chi/Qi-gong classes will take place once a week, for 10 consecutive weeks, at the facilities of the gyneco-oncology department. All patients will fill out the questionnaires at the beginning of the study, after 5 weeks, and upon the completion of the study (10 weeks).

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The Effect of Tai-chi/Qi-gong on Quality of Life (QOL), Sleep, and Fatigue in Patients With Gynecological Malignancies
Study Start Date :
Aug 1, 2014
Anticipated Primary Completion Date :
Aug 1, 2015
Anticipated Study Completion Date :
Aug 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: Tai-chi/Qi-gong

30 gynecological cancer patients scheduled for the first or second line of chemotherapy treatment will be recruited for this study to receive Tai-chi/qigong treatment initiated at the beginning of chemotherapy therapy, once a week (45 min each), for 10 weeks.

Other: Tai-chi/Qi-gong
Tai-chi/Qi-gong employs a series of positions and movements that are performed in a slow, flowing manner to help a person concentrate on breathing and motion. The treatments will take place once a week at the Dept. of the Gyneco-oncology and the patients will be instructed to practice tai-chi at home on a daily basis
Other Names:
  • Tai Chi
  • Qi-gong
  • Taichi
  • Qigong
  • No Intervention: Usual Care

    30 gynecological cancer patients scheduled for primary or secondary chemotherapy treatment, will be evaluated by the same measures as the intervention group.

    Outcome Measures

    Primary Outcome Measures

    1. Change in the Multidimensional Quality of Life Scale cancer MQOLS-CA [Week 0, Week 5, Week 10]

      The Multidimensional Quality of Life Scale cancer MQOLS-CA was written by Padilla (5) and translated into Hebrew by Dorit Pud (6).

    Secondary Outcome Measures

    1. Change in the Lee Fatigue Scale (LFS) [Week 0, Week 5, Week 10]

      The Lee Fatigue Scale (LFS). The questionnaire was compiled by Lee (7) and translated into Hebrew by Dr. Dorit Pud (6).

    2. Change in the Visual Analog Scale for Pain [Week 0, Week 5, Week 10]

    Other Outcome Measures

    1. Change in the White Blood Cell Count [Week 0, Week 3, Week 6, Week 9]

      Results of the routine blood exams will be documented

    2. Change in the Hemoglobin in blood [Week 0, Week 3, Week 6, Week 9]

      Results of the routine blood exams will be documented

    3. Change in the C-reactive protein in blood [Week 0, Week 3, Week 6, Week 9]

    4. Change in the Body Weight [Week 0, Week 5, Week 10]

    5. Change in the number of Emergency Room visits [Week 0, Week 5, Week 10]

      Emergency Room visits for nausea, vomiting, or dehydration

    6. Pattern of use of Complementary Medicine [Week 0, Week 5, Week 10]

      List of Complementary modalities used including Medical Cannabis

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Women with gynecological malignancies undergoing primary or secondary chemotherapy
    Exclusion Criteria:
    • Motor disability;

    • Less than 1 month since the last abdominal surgery;

    • Ascites

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Sheba Hospital Ramat Gan Israel

    Sponsors and Collaborators

    • Sheba Medical Center
    • Tel Aviv University

    Investigators

    • Principal Investigator: Dorit Gamus, M.D. Ph.D., Sheba Medical Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Dorit Gamus, Director, Complementary Medicine Service, Sheba Medical Center
    ClinicalTrials.gov Identifier:
    NCT01880996
    Other Study ID Numbers:
    • SHEBA-13-0112-DG-CTIL
    First Posted:
    Jun 19, 2013
    Last Update Posted:
    Jun 11, 2015
    Last Verified:
    Jun 1, 2015
    Keywords provided by Dorit Gamus, Director, Complementary Medicine Service, Sheba Medical Center
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 11, 2015